Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
CT ORDERConfidential treatment orderNov 16, 2017Open Confidential treatment order in HTML.Open Confidential treatment order in DOC file.Open Confidential treatment order in PDF file.Open Confidential treatment order in XLS file.
FWPFree Writing ProspectusAug 9, 2017Open Free Writing Prospectus in HTML.Open Free Writing Prospectus in DOC file.Open Free Writing Prospectus in PDF file.Open Free Writing Prospectus in XLS file.
305B2Initial statement filed pursuant to the Trust Indenture ActAug 8, 2017Open Initial statement filed pursuant to the Trust Indenture Act in HTML.Open Initial statement filed pursuant to the Trust Indenture Act in DOC file.Open Initial statement filed pursuant to the Trust Indenture Act in PDF file.Open Initial statement filed pursuant to the Trust Indenture Act in XLS file.
UPLOADCorrespondence from the SEC to the FilerMay 25, 2017Open Correspondence from the SEC to the Filer in HTML.Open Correspondence from the SEC to the Filer in DOC file.Open Correspondence from the SEC to the Filer in PDF file.Open Correspondence from the SEC to the Filer in XLS file.
CORRESPCorrespondence from the Filer to the SECMay 2, 2017Open Correspondence from the Filer to the SEC in HTML.Open Correspondence from the Filer to the SEC in DOC file.Open Correspondence from the Filer to the SEC in PDF file.Open Correspondence from the Filer to the SEC in XLS file.
UPLOADCorrespondence from the SEC to the FilerApr 28, 2017Open Correspondence from the SEC to the Filer in HTML.Open Correspondence from the SEC to the Filer in DOC file.Open Correspondence from the SEC to the Filer in PDF file.Open Correspondence from the SEC to the Filer in XLS file.
CT ORDERConfidential treatment orderApr 6, 2017Open Confidential treatment order in HTML.Open Confidential treatment order in DOC file.Open Confidential treatment order in PDF file.Open Confidential treatment order in XLS file.
CT ORDERConfidential treatment orderApr 5, 2017Open Confidential treatment order in HTML.Open Confidential treatment order in DOC file.Open Confidential treatment order in PDF file.Open Confidential treatment order in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2017Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2017Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2017Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 10, 2017Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 2, 2017Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in HTML.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in DOC file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in PDF file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file.
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsJan 30, 2017Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in HTML.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in DOC file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in PDF file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file.
SC 13G/AAmendment to a previously filed SC 13GJan 19, 2017Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information